Pardes Biosciences Inc (PRDS)
followers
·
Follow
Sector: | FINANCE |
Industry: | GENERAL FINANCE |
CEO: | Thomas G. Wiggans |
Employees: | 30 |
Web site: | pardesbio.com |
2173 SALK AVENUE, SUITE 250, PMB#052, CARLSBAD, CA, 92008
415-649-8758
|
• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know
-
Formally known as:
- FS Development Corp II
Are you looking for this stock instead?
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|
Pardes Biosciences, Inc. focuses on discovering, developing, and commercializing novel therapeutics. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome coronavirus 2 infections and associated diseases.